NextPlat (NASDAQ:NXPL) Shares Down 6% – Here’s What Happened

NextPlat Corp. (NASDAQ:NXPLGet Free Report) shares traded down 6% during trading on Monday . The stock traded as low as $0.4870 and last traded at $0.4910. 31,745 shares traded hands during mid-day trading, a decline of 31% from the average session volume of 46,277 shares. The stock had previously closed at $0.5221.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of NextPlat in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Get Our Latest Stock Report on NXPL

NextPlat Stock Performance

The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. The company’s 50 day moving average is $0.62 and its 200-day moving average is $0.70. The company has a market capitalization of $12.92 million, a P/E ratio of -1.64 and a beta of 1.23.

Hedge Funds Weigh In On NextPlat

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC purchased a new position in NextPlat Corp. (NASDAQ:NXPLFree Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat as of its most recent SEC filing. Institutional investors and hedge funds own 1.30% of the company’s stock.

About NextPlat

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.

Featured Articles

Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.